Total Payments
$2,177
2024 Payments
$17.12
Companies
32
Transactions
97
Medicare Patients
6,967
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$2,177 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,177 | 97 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $357.57 | 19 | $0 (2019) |
| Focal Therapeutics, Inc. | $219.50 | 3 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $181.54 | 11 | $0 (2021) |
| Genentech USA, Inc. | $166.38 | 2 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $151.12 | 10 | $0 (2020) |
| Foundation Medicine, Inc. | $118.13 | 6 | $0 (2019) |
| VIEWRAY TECHNOLOGIES INC | $112.38 | 2 | $0 (2017) |
| Amgen Inc. | $98.18 | 1 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $96.59 | 6 | $0 (2018) |
| Puma Biotechnology, Inc. | $75.81 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.12 | 1 | ABBVIE INC. ($17.12) |
| 2023 | $63.08 | 3 | Eisai Inc. ($44.09) |
| 2022 | $12.44 | 1 | Sun Pharmaceutical Industries Inc. ($12.44) |
| 2021 | $20.57 | 1 | AstraZeneca Pharmaceuticals LP ($20.57) |
| 2020 | $326.44 | 12 | Amgen Inc. ($98.18) |
| 2019 | $507.51 | 24 | Celgene Corporation ($193.17) |
| 2018 | $599.74 | 20 | Genentech USA, Inc. ($144.66) |
| 2017 | $629.92 | 35 | VIEWRAY TECHNOLOGIES INC ($112.38) |
All Payment Transactions
97 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/04/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: ONCOLOGY | ||||||
| 06/17/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $20.63 | General |
| Category: Oncology | ||||||
| 06/14/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $23.46 | General |
| Category: Oncology | ||||||
| 03/20/2023 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Prostate Cancer | ||||||
| 01/27/2022 | Sun Pharmaceutical Industries Inc. | YONSA (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: Oncology | ||||||
| 02/19/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.57 | General |
| 11/18/2020 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $22.41 | General |
| 11/17/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: ONCOLOGY | ||||||
| 08/04/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: ONCOLOGY | ||||||
| 03/13/2020 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Oncology | ||||||
| 03/06/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: ONCOLOGY | ||||||
| 02/24/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: ONCOLOGY | ||||||
| 02/19/2020 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $98.18 | General |
| Category: Inflammation | ||||||
| 02/05/2020 | Daiichi Sankyo Inc. | Turalio (Drug) | Food and Beverage | In-kind items and services | $31.80 | General |
| Category: Oncology | ||||||
| 01/30/2020 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Oncology | ||||||
| 01/17/2020 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Oncology | ||||||
| 01/03/2020 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.30 | General |
| 01/02/2020 | Daiichi Sankyo Inc. | Turalio (Drug) | Food and Beverage | In-kind items and services | $38.51 | General |
| Category: Oncology | ||||||
| 12/04/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2019 | Ipsen Biopharmaceuticals, Inc | SOMATULINE DEPOT (Drug), ONIVYDE | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Oncology/Endocrinology | ||||||
| 10/01/2019 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $21.72 | General |
| 09/18/2019 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $21.76 | General |
| 08/29/2019 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Immunology | ||||||
| 08/07/2019 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,633 | 3,495 | $1.9M | $343,149 |
| 2022 | 27 | 1,898 | 4,566 | $2.5M | $473,979 |
| 2021 | 24 | 1,580 | 3,183 | $1.7M | $296,933 |
| 2020 | 25 | 1,856 | 4,202 | $1.7M | $328,723 |
Total Patients
6,967
Total Services
15,446
Medicare Billing
$1.4M
Procedure Codes
104
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 106 | 335 | $342,672 | $52,931 | 15.4% |
| G6012 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | Office | 2023 | 15 | 197 | $140,585 | $43,031 | 30.6% |
| 77301 | High precision radiation therapy planning | Office | 2023 | 63 | 66 | $173,982 | $27,357 | 15.7% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2023 | 81 | 571 | $150,400 | $23,285 | 15.5% |
| 77263 | Complex radiation therapy planning | Office | 2023 | 129 | 146 | $131,283 | $20,031 | 15.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 144 | 144 | $65,215 | $19,544 | 30.0% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 112 | 287 | $105,711 | $16,352 | 15.5% |
| 77435 | Management of cranial lesion surgery using radiation over multiple sessions | Office | 2023 | 28 | 28 | $95,974 | $15,036 | 15.7% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2023 | 64 | 73 | $92,709 | $14,548 | 15.7% |
| 77295 | 3d radiation therapy planning | Office | 2023 | 60 | 66 | $91,873 | $14,287 | 15.6% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Office | 2023 | 72 | 100 | $82,414 | $12,572 | 15.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 99 | 113 | $39,584 | $11,905 | 30.1% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 114 | 349 | $68,187 | $10,639 | 15.6% |
| 57156 | Insertion of device into vagina for radiation therapy | Office | 2023 | 15 | 47 | $41,944 | $9,076 | 21.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 113 | $28,075 | $8,039 | 28.6% |
| 77470 | Special radiation treatment | Office | 2023 | 78 | 85 | $49,864 | $7,678 | 15.4% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 88 | 132 | $48,932 | $7,628 | 15.6% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Office | 2023 | 49 | 335 | $22,718 | $7,057 | 31.1% |
| 77770 | High dose radiation therapy, 1 channel | Office | 2023 | 15 | 48 | $29,420 | $4,597 | 15.6% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 17 | 55 | $26,414 | $4,365 | 16.5% |
| 77293 | Obtaining respiratory data needed to develop the optimal radiation treatment | Office | 2023 | 37 | 38 | $25,277 | $3,943 | 15.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 31 | 41 | $10,189 | $2,780 | 27.3% |
| 77333 | Design and construction of intermediate radiation treatment device | Office | 2023 | 35 | 36 | $11,811 | $1,810 | 15.3% |
| 77321 | Special radiation therapy planning for delivery of external radiation | Office | 2023 | 29 | 30 | $10,121 | $1,595 | 15.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $3,357 | $1,048 | 31.2% |
About Dr. Ray Lin, M.D
Dr. Ray Lin, M.D is a Radiation Oncology healthcare provider based in La Jolla, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437110996.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ray Lin, M.D has received a total of $2,177 in payments from pharmaceutical and medical device companies, with $17.12 received in 2024. These payments were reported across 97 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($2,177).
As a Medicare-enrolled provider, Lin has provided services to 6,967 Medicare beneficiaries, totaling 15,446 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Location La Jolla, CA
- Active Since 03/31/2006
- Last Updated 06/26/2009
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1437110996
Products in Payments
- Otezla (Drug) $222.96
- BioZorb (Device) $219.50
- KEYTRUDA (Biological) $137.62
- FOUNDATIONONE (Device) $118.13
- MRIDIAN (Device) $112.38
- OPDIVO (Biological) $96.59
- FASLODEX (Drug) $92.37
- Nerlynx (Drug) $75.81
- Turalio (Drug) $70.31
- Lenvima (Drug) $68.75
- Abraxane (Drug) $57.87
- Imbruvica (Drug) $47.74
- JADENU (Drug) $35.12
- VERZENIO (Drug) $31.20
- LYNPARZA (Drug) $28.89
- GILOTRIF (Drug) $28.47
- Cresemba (Drug) $23.94
- NO PRODUCT DISCUSSED (Drug) $23.63
- ULTOMIRIS (Drug) $23.59
- Cordran (Drug) $19.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Radiation Oncology Doctors in La Jolla
Dr. Loren Mell, M.d, M.D
Radiation Oncology — Payments: $22,600
Radiation Oncology $22,600
Dr. Kevin Murphy, M.d, M.D
Radiation Oncology — Payments: $11,745
Radiation Oncology $11,745
Dr. Jona Hattangadi-Gluth, Md, MD
Radiation Oncology — Payments: $4,070
Radiation Oncology $4,070
Dr. Ajay Pal Sandhu, M.d, M.D
Radiation Oncology — Payments: $1,278
Radiation Oncology $1,278
Chien Chen, M.d., Ph.d, M.D., PH.D
Radiation Oncology — Payments: $336.12
Radiation Oncology $336.12
Dr. Catheryn Yashar, M.d, M.D
Radiation Oncology — Payments: $230.64
Radiation Oncology $230.64